Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Lobo

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Obstetrics and Gynecology|January 16, 2016
Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrheaEnrico Carmina, Franca Fruzzetti, Roger A Lobo
Obstetrics and Gynecology|January 25, 2012
A 20-year follow-up of young women with polycystic ovary syndromeEnrico Carmina, Anna Maria Campagna, Roger A Lobo
Circulation|July 9, 2003
Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular diseaseHoward N Hodis, Wendy J Mack, Roger A Lobo
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 9, 2014
Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndromeDaniel H Kort, Alessandra Kostolias, Chantae Sullivan, et al.
Journal of Assisted Reproduction and Genetics|October 12, 2012
Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulinLiyun Li, Michel Ferin, Mark V Sauer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 4, 2021
Do lipid parameters change during clomiphene citrate or letrozole therapy in women being treated for infertility? A pilot studySelma Amrane, Sally F Vitez, Katherine L Palmerola, et al.
Fertility and Sterility|June 28, 2011
Words of thanks to Dr. Alan H. DeCherneyDolores J Lamb, William E Gibbons, Roger A Lobo, et al.
Fertility and Sterility|October 30, 2012
Best practices of ASRM and ESHRE: a journey through reproductive medicineLuca Gianaroli, Catherine Racowsky, Joep Geraedts, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 25, 2016
Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomesKatherine L Palmerola, Jennifer Y Hsu, Lisa C Grossman, et al.
Atherosclerosis|July 26, 2005
Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT)Juliana Hwang, Wendy J Mack, Min Xiang, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|January 16, 2016
Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrheaEnrico Carmina, Franca Fruzzetti, Roger A Lobo
Obstetrics and Gynecology|January 25, 2012
A 20-year follow-up of young women with polycystic ovary syndromeEnrico Carmina, Anna Maria Campagna, Roger A Lobo
Circulation|July 9, 2003
Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular diseaseHoward N Hodis, Wendy J Mack, Roger A Lobo
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 9, 2014
Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndromeDaniel H Kort, Alessandra Kostolias, Chantae Sullivan, et al.
Journal of Assisted Reproduction and Genetics|October 12, 2012
Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulinLiyun Li, Michel Ferin, Mark V Sauer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 4, 2021
Do lipid parameters change during clomiphene citrate or letrozole therapy in women being treated for infertility? A pilot studySelma Amrane, Sally F Vitez, Katherine L Palmerola, et al.
Fertility and Sterility|June 28, 2011
Words of thanks to Dr. Alan H. DeCherneyDolores J Lamb, William E Gibbons, Roger A Lobo, et al.
Fertility and Sterility|October 30, 2012
Best practices of ASRM and ESHRE: a journey through reproductive medicineLuca Gianaroli, Catherine Racowsky, Joep Geraedts, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 25, 2016
Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomesKatherine L Palmerola, Jennifer Y Hsu, Lisa C Grossman, et al.
Atherosclerosis|July 26, 2005
Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT)Juliana Hwang, Wendy J Mack, Min Xiang, et al.
Pageof 3